| Good Shepherd Home-bethlehem | |
| 2855 Schoenersville Road, Bethlehem, Pennsylvania 18017 | |
| (610) 807-5600 | |
| Name | Good Shepherd Home-bethlehem |
|---|---|
| Location | 2855 Schoenersville Road, Bethlehem, Pennsylvania |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 60 |
| Occupancy Rate | 96.17% |
| Medicare ID (CCN) | 396108 |
| Legal Business Name | Good Shepherd Home Long Term Care Facility, Inc |
| Ownership Type | Non Profit - Corporation |
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces that it has entered into an agreement with the American Association for Geriatric Psychiatry (AAGP) to publish The American Journal of Geriatric Psychiatry (AJGP) beginning in January 2013.
Duke biomedical engineers have received more than $2.2 million from the National Institutes of Health (NIH) to continue their explorations of how the complex moving and flexing of blood vessels during a heartbeat might contribute to heart disease.
Clients of NextGen Healthcare Information Systems, Inc. have secured nearly $2 million in reimbursements from the Physician Quality Reporting Initiative program by leveraging NextGen Ambulatory EHR and the NextGen Health Quality Measures Reporting Module, a proprietary, clinical data repository designed for automated registry reporting of clinical outcomes and quality measure data for pay-for-performance programs.
The HER2 gene is a well-known driver of breast cancer, where changes in this gene are found in about 1-in-5 cases of the disease. HER2 also contributes to about 3 percent of lung cancers, representing about 6,500 patients per year.
Osiris Therapeutics, Inc. today announced that it has achieved a $750,000 milestone payment from the Juvenile Diabetes Research Foundation (JDRF) for completing enrollment in a Phase II clinical trial evaluating Prochymal, an adult mesenchymal stem cell (MSC) therapy, as a treatment for patients recently diagnosed with type 1 diabetes. The milestone is the fourth in a series of payments resulting from JDRF's partnership with Osiris for the development of a therapy for type 1 diabetes.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 4.24 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 1.72 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 57.14 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.84 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.84 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 92.83 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 22.42 | 14.2 |